24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2026
2026 VC Survey
Boarding Pass
CTalk
BiblioTech
Corporate
Appointments
Tech Gateways
@Finance
Ctech Testimonials
Projects
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Biomed
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
Projects
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
10:27
Israeli researchers develop AI method to speed up breast cancer MRI scans
09:56
How Chinese cars became a national security issue in Israel
09:36
Israel is not losing its growth market. It is reorganizing it.
21:45
Germany’s missile search draws attention to secretive startup Covenant
More stories
Buzz
Most popular
Daily
Weekly
1
Anduril explores Israeli expansion as defense-tech boom accelerates
2
Amdocs’ layoffs fail to halt share slide
3
Marvell CTO: "The market has finally reached the bottleneck we solve"
4
Germany’s missile search draws attention to secretive startup Covenant
5
Unicorn Artlist to cut 200 jobs, 40% of workforce, despite surpassing $300 million ARR
More news
Biomed
9 stories about Biomed
Fourth Time’s the Charm for Entera Bio IPO
01.07.18
|
Dror Reich
The Israel-based oral drug developer listed on Nasdaq on Thursday, pricing 1.4 million units of one share and one warrant at $8 each
Entera Bio Gives Nasdaq IPO Another Shot
21.05.18
|
Dror Reich
This is the fourth time since 2014 that the Jerusalem-based biomed company files for an initial public offering on Nasdaq
Pharma Company Opko Health Retracts Decision to Delist From the Tel Aviv Stock Exchange
29.04.18
|
Racheli Bindman
Dually listed on Nasdaq and TASE, Opko first submitted a request to delist from the TASE in early April
An Israeli Company Wants to Treat Tourette Syndrome With Cannabis
09.04.18
|
Lilach Baumer
Therapix Biosciences announced the successful completion of phase 2 clinical trial of its cannabinoid-based drug, conducted at Yale University Monday
For the Fourth Time, Entera Bio Tries for Nasdaq IPO
08.01.18
|
Dror Reich
The Jerusalem-based biomed company plans to raise $55 million, with Oppenheimer & Co. as the sole underwriter
Biomed Company Protalix to Lay Off a Fifth of its Workforce
26.11.17
|
Dror Reich
The Israel-based NYSE American-listed company is currently undergoing a streamlining process
Entera Bio Files for Nasdaq IPO
12.11.17
|
Lilach Baumer
The clinical stage company develops treatments mostly for osteoporosis and bone disorders
Collplant Takes a Step Towards 3D Organ Printing
17.10.17
|
Lilach Baumer
The Israel-based company develops collagen-based biological ink for 3D organ printing
IPO Hopeful Entera Bio Moves to Better Position
13.09.17
|
Dror Reich
Clinical-stage company Entera Bio develops pioneering technology for orphan disease hypoparathyroidism
Previous Articles
